List of Contract Manufacturing Stocks
Contract Manufacturing is part of the Pharma Services group in the Healthcare sector. Its 66 US-listed companies are worth $694.23 billion between them. The median is $366.89 million. 4 have Contract Manufacturing as their primary business, and 62 more run a substantial one alongside another industry.
|
List of Contract Manufacturing Stocks
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Company | Mkt Cap | Price | Chg % | 1Y | Revenue (TTM) | Revenue (Qtr) | Net Income (TTM) | P/E | Net Margin (TTM) | Div. Yield | Why this company is listed here |
| TMO 2nd | Thermo Fisher Scientific | $257.55Bn | 696.55 | +3.46% | +31.95% | 46.34Bn | 11.99Bn | 6.99Bn | 36.16 | 15.04% | 0.00% | |
| PFE 2nd | Pfizer | $167.74Bn | 29.43 | +0.72% | +20.66% | 63.70Bn | 15.03Bn | 4.36Bn | 38.76 | 6.80% | 0.06% | |
| TEVA 2nd | Teva Pharmaceutical Industries | $47.92Bn | 41.12 | +0.93% | +107.89% | 17.32Bn | 4.14Bn | 708.00Mn | 68.18 | 4.08% | 0.00% | |
| ZTS 2nd | Zoetis | $32.49Bn | 78.46 | +4.17% | -44.79% | 9.52Bn | 2.47Bn | 2.62Bn | 12.72 | 27.49% | 0.03% | |
| WST 2nd | West Pharmaceutical Services | $26.98Bn | 383.25 | +2.26% | +45.75% | 3.33Bn | 872.30Mn | 564.90Mn | 48.16 | 16.98% | 0.00% | |
| IFF 2nd | International Flavors & Fragrances | $23.05Bn | 90.28 | +0.73% | +45.78% | 9.98Bn | 1.95Bn | 295.00Mn | 33.28 | 6.98% | 0.02% | |
| STE 2nd | Steris | $21.87Bn | 224.29 | +3.24% | -5.27% | 6.04Bn | 1.49Bn | 808.10Mn | 26.96 | 13.33% | 0.01% | |
| VTRS 2nd | Viatris | $20.93Bn | 18.22 | +4.47% | +82.57% | 14.74Bn | 3.76Bn | -410.70Mn | -51.64 | -2.79% | 0.00% | |
| CRL 2nd | Charles River Laboratories International | $14.62Bn | 306.39 | +1.48% | +79.47% | 4.00Bn | 1.00Bn | -239.23Mn | -60.24 | -5.96% | 0.00% | |
| RDY 2nd | Dr Reddys Laboratories | $10.78Bn | 12.92 | +1.33% | -8.17% | 3.66Bn | 852.47Mn | 367.21Mn | 25.26 | 11.78% | 0.00% | |
| PODD 2nd | Insulet | $9.62Bn | 138.77 | +3.61% | -55.59% | 3.05Bn | 801.70Mn | 375.30Mn | 26.21 | 12.29% | 0.00% | |
| IONS 2nd | Ionis Pharmaceuticals | $7.31Bn | 44.12 | +3.33% | -39.05% | 874.09Mn | 267.95Mn | -565.17Mn | -13.00 | -64.66% | 0.00% | |
| ALKS 2nd | Alkermes | $6.72Bn | 40.10 | +2.61% | +24.42% | 1.67Bn | 496.01Mn | 66.12Mn | 108.64 | 3.97% | 0.00% | |
| LNTH 2nd | Lantheus Holdings | $6.53Bn | 99.99 | -0.01% | +76.91% | 1.56Bn | 388.18Mn | 275.31Mn | 23.65 | 17.69% | 0.00% | |
| LGND 2nd | Ligand Pharmaceuticals | $5.95Bn | 298.50 | +1.19% | +62.85% | 290.54Mn | 63.69Mn | 197.22Mn | 30.08 | 67.88% | 0.00% | |
| GRFS 2nd | Grifols | $5.13Bn | 7.54 | +4.14% | -21.38% | — | — | — | 11.30 | — | 0.00% | |
| OGN 2nd | Organon | $3.62Bn | 13.77 | +0.22% | +44.19% | 6.13Bn | 1.56Bn | 209.00Mn | 17.27 | 3.41% | 0.00% | |
| TLX 2nd | Telix Pharmaceuticals | $3.58Bn | 10.57 | -0.75% | -4.00% | — | — | — | — | — | 0.00% | |
| LQDA 2nd | Liquidia | $3.10Bn | 34.78 | +2.47% | +50.17% | 450.91Mn | 171.68Mn | 138.61Mn | 21.87 | 30.74% | 0.00% | |
| ADMA 2nd | Adma Biologics | $2.42Bn | 10.73 | +3.77% | -28.89% | 512.28Mn | 124.40Mn | 168.96Mn | 14.95 | 32.98% | 0.00% | |
| BHC 2nd | Bausch Health Companies | $2.36Bn | 6.32 | +7.30% | +4.98% | 10.85Bn | 2.85Bn | -1.10Bn | -2.16 | -10.12% | 0.00% | |
| NVAX 2nd | Novavax | $2.11Bn | 12.82 | +1.42% | +43.88% | 413.80Mn | 56.70Mn | -247.76Mn | -7.21 | -59.88% | 0.00% | |
| MRVI 2nd | Maravai Lifesciences Holdings | $1.84Bn | 7.07 | +7.94% | +109.79% | 208.78Mn | 51.44Mn | -136.08Mn | -13.36 | -37.07% | 0.00% | |
| AMPH 2nd | Amphastar Pharmaceuticals | $1.12Bn | 26.42 | +1.30% | +14.17% | 730.02Mn | 183.90Mn | 78.55Mn | 14.53 | 10.76% | 0.00% | |
| IART 2nd | Integra Lifesciences Holdings | $1.05Bn | 13.53 | +2.66% | -4.92% | 1.65Bn | 418.76Mn | -7.24Mn | -143.96 | -0.44% | 0.00% | |
| QDEL 2nd | QuidelOrtho | $950.05Mn | 13.91 | +0.29% | -49.07% | -211.90Mn | -62.80Mn | -1.05Bn | -0.83 | — | 0.00% | |
| MGTX 2nd | MeiraGTx Holdings | $931.52Mn | 9.89 | +5.10% | +21.50% | 400.90Mn | 321.43Mn | 86.45Mn | 9.98 | 21.56% | 0.00% | |
| LXRX 2nd | Lexicon Pharmaceuticals | $737.34Mn | 1.65 | +3.12% | +7.84% | 41.47Mn | 692.00K | -61.12Mn | -11.14 | -147.38% | 0.00% | |
| AVR 2nd | Anteris Technologies Global | $619.53Mn | 6.36 | +1.60% | +34.18% | 2.24Mn | 1.01Mn | -102.91Mn | -5.84 | -4,589.96% | 0.00% | |
| AQST 2nd | Aquestive Therapeutics | $509.58Mn | 4.06 | -11.93% | -44.69% | 54.09Mn | 13.82Mn | -78.23Mn | -6.13 | -144.63% | 0.00% | |
| EVO 2nd | Evotec SE | $504.89Mn | 1.42 | +0.00% | -63.87% | — | — | — | — | — | 0.00% | |
| RGNX 2nd | Regenxbio | $387.81Mn | 7.16 | +4.07% | -41.79% | 189.45Mn | 108.02Mn | -177.27Mn | -2.13 | -93.56% | 0.00% | |
| EBS 2nd | Emergent BioSolutions | $368.33Mn | 7.18 | +4.06% | -25.21% | 770.20Mn | 234.30Mn | -176.80Mn | -1.86 | -22.96% | 0.00% | |
| EMBC 2nd | Embecta | $365.45Mn | 6.45 | +4.37% | -53.53% | 1.02Bn | 271.70Mn | 87.50Mn | 4.19 | 8.59% | 0.07% | |
| ELTP 2nd | Elite Pharmaceuticals | $269.28Mn | 0.25 | +0.00% | -59.02% | 141.01Mn | 32.36Mn | 56.67Mn | 4.75 | 40.19% | 0.00% | |
| OSUR 2nd | Orasure Technologies | $268.19Mn | 3.81 | +2.70% | +24.51% | 88.36Mn | 100.00K | -49.44Mn | -5.44 | -55.96% | 0.00% | |
| EYPT 2nd | EyePoint | $266.84Mn | 3.14 | +4.32% | -73.23% | 2.79Mn | 507.00K | -306.64Mn | -0.12 | -10,994.73% | 0.00% | |
| UTMD 2nd | Utah Medical Products | $238.47Mn | 74.92 | +0.17% | +23.88% | 36.11Mn | 8.53Mn | 10.49Mn | 22.68 | 29.04% | 0.00% | |
| LFCR | Lifecore Biomedical, Inc. \De\ | $238.45Mn | 6.44 | +0.31% | -3.74% | — | — | — | — | — | — | |
| MGNX 2nd | Macrogenics | $214.49Mn | 3.37 | +1.81% | +99.41% | 167.67Mn | 32.83Mn | -14.59Mn | -14.43 | -8.70% | 0.00% | |
| STRO 2nd | Sutro Biopharma | $189.96Mn | 11.46 | +8.94% | +46.92% | 94.92Mn | 9.84Mn | -153.65Mn | -1.21 | -161.87% | 0.00% | |
| CDXS 2nd | Codexis | $124.29Mn | 1.36 | +5.43% | -50.36% | 77.68Mn | 14.92Mn | -30.72Mn | -3.99 | -39.55% | 0.00% | |
| APYX 2nd | Apyx Medical | $107.82Mn | 2.56 | -0.39% | -17.68% | 58.42Mn | 13.88Mn | -8.41Mn | -12.34 | -14.78% | 0.00% | |
| NTRB 2nd | NutriBand | $76.22Mn | 6.27 | -0.79% | -16.73% | 1.62Mn | 437.51K | -6.96Mn | -10.11 | -430.43% | 0.00% | |
| PTHS 2nd | Pelthos Therapeutics | $75.86Mn | 20.40 | +0.20% | -26.17% | 43.30Mn | 15.60Mn | -86.39Mn | -0.83 | -199.50% | 0.00% | |
| XBIT 2nd | XBiotech | $65.85Mn | 2.16 | +0.00% | -14.96% | — | — | -41.38Mn | -1.47 | — | 0.00% | |
| HYFT 2nd | MindWalk Holdings | $65.40Mn | 1.40 | +2.19% | -18.13% | 11.72Mn | 2.75Mn | -12.32Mn | -4.97 | -105.16% | 0.00% | |
| BHST 2nd | Bioharvest Sciences | $38.99Mn | 1.72 | -1.71% | -86.40% | 35.48Mn | 8.84Mn | -11.07Mn | -3.04 | -31.21% | 0.00% | |
| CELU 2nd | Celularity | $38.81Mn | 1.33 | +1.53% | -38.71% | 18.97Mn | 3.85Mn | -71.09Mn | -0.47 | -375.92% | 0.00% | |
| NSYS 2nd | Nortech Systems | $29.45Mn | 10.32 | -2.55% | +4.24% | — | — | — | — | — | 0.00% | |
| LASE 2nd | Laser Photonics | $28.72Mn | 0.73 | -2.67% | -82.66% | 6.17Mn | 1.81Mn | -20.23Mn | -0.73 | -596.66% | 0.00% | |
| ABVC 2nd | Abvc Biopharma | $23.71Mn | 0.92 | -9.80% | -68.28% | — | — | -7.60Mn | -3.37 | — | 0.00% | |
| COSM 2nd | Cosmos Health | $20.37Mn | 0.34 | -10.53% | -72.80% | 73.73Mn | 18.99Mn | -24.39Mn | -0.81 | -33.08% | 0.00% | |
| SCLX 2nd | Scilex Holding | $19.84Mn | 2.82 | -1.05% | -68.39% | 31.66Mn | 7.64Mn | -493.00Mn | -0.04 | -1,416.35% | 0.00% | |
| DQWS 2nd | DSwiss | $16.55Mn | 0.08 | +0.00% | +166.67% | 1.48Mn | 107.34K | -245.94K | -67.30 | -16.58% | — | |
| PLUR 2nd | Pluri | $10.17Mn | 0.94 | +1.08% | -79.16% | — | — | — | 0.00 | — | 0.00% | |
| NAII | Natural Alternatives International | $6.75Mn | 1.12 | -1.75% | -59.27% | 142.52Mn | 34.51Mn | -20.70Mn | -0.33 | -14.52% | 0.00% | |
| VSBC 2nd | Vitaspring Biomedical | $6.21Mn | 0.03 | +0.00% | -97.00% | — | — | -455.64K | -13.60 | — | — | |
| GELS | Gelteq | $4.71Mn | 0.44 | -2.22% | -65.62% | — | — | — | — | — | 0.00% | |
| CLGN 2nd | CollPlant Biotechnologies | $4.71Mn | 3.68 | -10.02% | -84.67% | 424.00K | 108.00K | -12.51Mn | -0.35 | -2,951.18% | 0.00% | |
| LGVN 2nd | Longeveron | $4.54Mn | 1.50 | -13.29% | -82.01% | 1.19Mn | 287.00K | -23.43Mn | -0.19 | -1,977.59% | 0.00% | |
| AIDX 2nd | 20 | $3.43Mn | 0.28 | -9.68% | — | 2.17Mn | 730.57K | -5.29Mn | -0.45 | -298.18% | 0.00% | |
| ADMT 2nd | Adm Tronics Unlimited | $2.70Mn | 0.04 | +0.00% | -55.56% | 3.24Mn | 866.26K | -395.64K | -8.23 | -12.21% | 0.00% | |
| NXGL | Nexgel | $2.51Mn | 5.18 | -5.13% | +104.74% | 12.30Mn | 3.69Mn | -5.76Mn | -0.43 | -48.15% | 0.00% | |
| SKVI 2nd | Skinvisible | $1.08Mn | 0.20 | +0.00% | -68.75% | 20.00K | 5.00K | -1.03Mn | -1.05 | -5,156.60% | — | |
| SCNI 2nd | Scinai Immunotherapeutics | $312.14K | 0.90 | +2.27% | -93.48% | 1.72Mn | 460.00K | -2.56Mn | -0.07 | -148.66% | 0.00% | |
Showing 30 of 66 Contract Manufacturing companies
Create a free account to see the remaining 36, sort the full list on any column, and choose your own metrics.
Free, no card. Already have an account? Sign in.
No companies match that filter.
- 2nd a substantial business here, but not the company’s largest
- Prices and market caps as of the last close
- Click any column heading to sort
About this list
How many Contract Manufacturing stocks are there?
This list holds 66 US-listed companies, of which 4 have Contract Manufacturing as their primary business. The rest operate a substantial Contract Manufacturing business alongside something else, which is why they appear here as well as on their own primary list.
How is this list put together?
Every US-listed company is classified under BQ-MICS, our own multi-industry classification system. Unlike a single-label scheme it assigns each company a primary industry AND any secondary industries it genuinely operates in, and it records the reasoning behind every assignment — which you can read on each row of the table above.
Why do some companies appear on more than one list?
Because they genuinely operate more than one business. A retailer running a large cloud division belongs on both lists, and a classification that forces it onto one is hiding half the company. Every appearance beyond the primary one is labelled as secondary, and the toggle above the table hides them if you only want pure plays.
How often is this list updated?
Prices, market caps and performance figures refresh with each session's close. The classification itself is reviewed whenever a company's filings change what it does — a new segment, a disposal or an acquisition — rather than on a fixed calendar.
Can I screen these companies on other metrics?
Yes. Use Edit Columns above the table to add any of 1,000+ financial metrics and ratios to this list, or open the full stock screener to filter the whole market on them.